Cargando…

Prevalence of symptoms, comorbidities, fibrin amyloid microclots and platelet pathology in individuals with Long COVID/Post-Acute Sequelae of COVID-19 (PASC)

BACKGROUND: Fibrin(ogen) amyloid microclots and platelet hyperactivation previously reported as a novel finding in South African patients with the coronavirus 2019 disease (COVID-19) and Long COVID/Post-Acute Sequelae of COVID-19 (PASC), might form a suitable set of foci for the clinical treatment o...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pretorius, Etheresia, Venter, Chantelle, Laubscher, Gert Jacobus, Kotze, Maritha J, Oladejo, Sunday O., Watson, Liam R., Rajaratnam, Kanshu, Watson, Bruce W., Kell, Douglas B.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9356426/ https://www.ncbi.nlm.nih.gov/pubmed/35933347 http://dx.doi.org/10.1186/s12933-022-01579-5

Ejemplares similares

A central role for amyloid fibrin microclots in long COVID/PASC: origins and therapeutic implications
por: Kell, Douglas B., et al.
Publicado: (2022)

Proteomics of fibrin amyloid microclots in long COVID/post-acute sequelae of COVID-19 (PASC) shows many entrapped pro-inflammatory molecules that may also contribute to a failed fibrinolytic system
por: Kruger, Arneaux, et al.
Publicado: (2022)

TEG(®), Microclot and Platelet Mapping for Guiding Early Management of Severe COVID-19 Coagulopathy
por: Laubscher, Gert Jacobus, et al.
Publicado: (2021)

Persistent clotting protein pathology in Long COVID/Post-Acute Sequelae of COVID-19 (PASC) is accompanied by increased levels of antiplasmin
por: Pretorius, Etheresia, et al.
Publicado: (2021)

SARS-CoV-2 spike protein S1 induces fibrin(ogen) resistant to fibrinolysis: implications for microclot formation in COVID-19
por: Grobbelaar, Lize M., et al.
Publicado: (2021)

Accelerating discovery: A novel flow cytometric method for detecting fibrin(ogen) amyloid microclots using long COVID as a model
por: Turner, Simone, et al.
Publicado: (2023)

Prevalence of readily detected amyloid blood clots in ‘unclotted’ Type 2 Diabetes Mellitus and COVID-19 plasma: a preliminary report
por: Pretorius, Etheresia, et al.
Publicado: (2020)

Erythrocyte, Platelet, Serum Ferritin, and P-Selectin Pathophysiology Implicated in Severe Hypercoagulation and Vascular Complications in COVID-19
por: Venter, Chantelle, et al.
Publicado: (2020)

The Occurrence of Hyperactivated Platelets and Fibrinaloid Microclots in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)
por: Nunes, Jean M., et al.
Publicado: (2022)

Detection of Citrullinated Fibrin in Plasma Clots of Rheumatoid Arthritis Patients and Its Relation to Altered Structural Clot Properties, Disease-Related Inflammation and Prothrombotic Tendency
por: Bezuidenhout, Johannes A., et al.
Publicado: (2020)

Covid-19: The Rollercoaster of Fibrin(Ogen), D-Dimer, Von Willebrand Factor, P-Selectin and Their Interactions with Endothelial Cells, Platelets and Erythrocytes
por: Grobler, Corlia, et al.
Publicado: (2020)

Sleep Disturbance Severity and Correlates in Post-acute Sequelae of COVID-19 (PASC)
por: Pena-Orbea, Cinthya, et al.
Publicado: (2023)

The pathophysiology of postacute sequelae of COVID-19 (PASC): Possible role for persistent inflammation
por: Marshall, Gailen D.
Publicado: (2023)

To What Extent Are the Terminal Stages of Sepsis, Septic Shock, Systemic Inflammatory Response Syndrome, and Multiple Organ Dysfunction Syndrome Actually Driven by a Prion/Amyloid Form of Fibrin?
por: Kell, Douglas B., et al.
Publicado: (2018)

Lipopolysaccharide-binding protein (LBP) reverses the amyloid state of fibrin seen in plasma of type 2 diabetics with cardiovascular co-morbidities
por: Pretorius, Etheresia, et al.
Publicado: (2017)

Lipopolysaccharide-binding protein (LBP) can reverse the amyloid state of fibrin seen or induced in Parkinson's disease
por: Pretorius, Etheresia, et al.
Publicado: (2018)

The Potential of LPS-Binding Protein to Reverse Amyloid Formation in Plasma Fibrin of Individuals With Alzheimer-Type Dementia
por: Pretorius, Etheresia, et al.
Publicado: (2018)

Iron-Induced Fibrin in Cardiovascular Disease
por: Lipinski, Boguslaw, et al.
Publicado: (2013)

Mechanisms, Effects, and Management of Neurological Complications of Post-Acute Sequelae of COVID-19 (NC-PASC)
por: Ong, Ian Z., et al.
Publicado: (2023)

Editorial: Post-Acute Sequelae of COVID-19 infection (PASC): Implications for geriatric and neurological care
por: Ng, Ted Kheng Siang, et al.
Publicado: (2023)

Anticoagulants and Immunosuppressants in COVID-19: Bullets to Defeat MicroCLOTS
por: Turi, S, et al.
Publicado: (2020)

Substantial fibrin amyloidogenesis in type 2 diabetes assessed using amyloid-selective fluorescent stains
por: Pretorius, Etheresia, et al.
Publicado: (2017)

Post-acute sequelae of COVID-19 (PASC): a meta-narrative review of pathophysiology, prevalence, and management
por: Munipalli, Bala, et al.
Publicado: (2022)

Post-Acute Sequelae of COVID-19 (PASC) in Pediatrics: Factors That Impact Symptom Severity and Referral to Treatment
por: Soprano, Catherine M., et al.
Publicado: (2023)

The potential role of ischaemia–reperfusion injury in chronic, relapsing diseases such as rheumatoid arthritis, Long COVID, and ME/CFS: evidence, mechanisms, and therapeutic implications
por: Kell, Douglas B., et al.
Publicado: (2022)

Long COVID or Post-acute Sequelae of COVID-19 (PASC): An Overview of Biological Factors That May Contribute to Persistent Symptoms
por: Proal, Amy D., et al.
Publicado: (2021)

Case series: Maraviroc and pravastatin as a therapeutic option to treat long COVID/Post-acute sequelae of COVID (PASC)
por: Patterson, Bruce K., et al.
Publicado: (2023)

Profound Morphological Changes in the Erythrocytes and Fibrin Networks of Patients with Hemochromatosis or with Hyperferritinemia, and Their Normalization by Iron Chelators and Other Agents
por: Pretorius, Etheresia, et al.
Publicado: (2014)

OBJECTIVE CARDIOVASCULAR AUTONOMIC ABNORMALITIES IN POST-ACUTE SEQUELAE OF COVID-19 (PASC): OVERALL AND SEX-BASED PREVALENCE
por: Hira, R., et al.
Publicado: (2022)

Repurposing exercise training and pharmacological therapies to address the post-acute sequelae of COVID-19 (PASC) in diabetes mellitus
por: Jie Chee, Ying, et al.
Publicado: (2023)

The Role of Iron-Induced Fibrin in the Pathogenesis of Alzheimer’s Disease and the Protective Role of Magnesium
por: Lipinski, Boguslaw, et al.
Publicado: (2013)

Gingipain R1 and Lipopolysaccharide From Porphyromonas gingivalis Have Major Effects on Blood Clot Morphology and Mechanics
por: Nunes, J. Massimo, et al.
Publicado: (2020)

Pathogenic mechanisms of post-acute sequelae of SARS-CoV-2 infection (PASC)
por: Sherif, Zaki A, et al.
Publicado: (2023)

(PO-071) A Group Psychotherapy for Patients with Post-Acute Sequelae of COVID-19 (PASC) Experiencing Psychological Stress
por: Padda, Karanbir, et al.
Publicado: (2022)

Signatures of Mitochondrial Dysfunction and Impaired Fatty Acid Metabolism in Plasma of Patients with Post-Acute Sequelae of COVID-19 (PASC)
por: Guntur, Vamsi P., et al.
Publicado: (2022)

Immune mechanisms underlying COVID-19 pathology and post-acute sequelae of SARS-CoV-2 infection (PASC)
por: Mohandas, Sindhu, et al.
Publicado: (2023)

Unraveling pathophysiologic mechanisms contributing to symptoms in patients with post‐acute sequelae of COVID‐19 (PASC): A retrospective study
por: Dierckx, Wendel, et al.
Publicado: (2023)

MicroCLOTS pathophysiology in coronavirus disease 2019
por: Renzi, Samuele, et al.
Publicado: (2023)

Both lipopolysaccharide and lipoteichoic acids potently induce anomalous fibrin amyloid formation: assessment with novel Amytracker™ stains(†)
por: Pretorius, Etheresia, et al.
Publicado: (2018)

Increased serum 1,25-dihydroxyvitamin D levels in gynecologic cancer patients with Post-Acute-Covid-Sequela (PASC)/Long COVID
por: Bellone, Stefania, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_gbmocbqec9qfkmlmnf06gnkhld